Compounds > diclofenac

diclofenac and sulindac sulfide

diclofenac has been researched along with sulindac sulfide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bain, G; Beher, D; Chen, W; Jiang, X; Munoz, B; Peachey, J; Prasit, P; Shearman, MS; St-Jacques, R; Stock, N; Williamson, TL; Wrigley, JD1
Barreiro, EJ; Fraga, CA; Lima, LM; Romeiro, NC; Sant'Anna, CM1
Brünnert, D; Bruns, I; Cadeddu, RP; Czibere, A; Fröbel, J; Haas, R; Hartwig, S; Lehr, S; Prenzel, T; Schroeder, T; Singh, R; Wilk, CM; Zerbini, LF1
Bhasin, M; Cordeiro, J; Correa, RG; Czibere, A; Fisher, PB; Gu, X; Li, L; Libermann, TA; Sarkar, D; Simabuco, FM; Tamura, RE; Wang, Y; Zerbini, LF; Zhou, JR1

Other Studies

4 other study(ies) available for diclofenac and sulindac sulfide

ArticleYear
The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.
    Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Flurbiprofen; Mice; Peptide Fragments

2006
NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Catalytic Domain; Computational Biology; Drug Design; Ligands; Models, Molecular; PPAR gamma; Protein Conformation; Software

2008
The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
    Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Cell Cycle Proteins; Cell Differentiation; Cell Survival; Cloning, Molecular; Diclofenac; Flow Cytometry; Fos-Related Antigen-2; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Vectors; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid, Acute; Nuclear Proteins; Proto-Oncogene Proteins c-jun; RNA Interference; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulindac; Transcription Factor AP-1; Transcriptional Activation

2011
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Diclofenac; Drug Synergism; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mice; Mice, SCID; NF-kappa B; Nuclear Proteins; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sesquiterpenes; Sulindac; Tumor Burden; Xenograft Model Antitumor Assays

2011